Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horgos Yaoyue Consulting is a Chinese investment and consulting firm that functions as a strategic holding entity within the life sciences sector. The company is most notably recognized as a major shareholder of WuXi AppTec, one of the world's leading contract research, development, and manufacturing organizations (CRDMO). Registered in the Horgos special economic zone, it serves as a vehicle for the founders and key executives of the WuXi ecosystem to manage their equity interests and corporate governance. While the firm does not engage in direct drug discovery or clinical development, its operations are central to the financial and strategic management of significant biotech assets. Consequently, it plays a supportive role in the broader pharmaceutical R&D landscape through its affiliations and investment activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 霍尔果斯邀月咨询.